UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples.

Riazi, A; Hobart, JC; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2002) Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry , 73 (6) 701 - 704.

Full text not available from this repository.

Abstract

The psychometric properties of rating scales are sample dependent and need evaluations in different samples. The Multiple Sclerosis Impact Scale (MSIS-29), a new patient based rating scale for multiple sclerosis (MS) was predominantly developed from a community based sample derived from the MS Society. A number of important patient characteristics of this sample remain unknown. The aim of the study was to evaluate five psychometric properties of the MSIS-29 in three hospital based samples: people admitted for rehabilitation, people admitted for intravenous corticosteroid treatment for MS relapses, and people with primary progressive MS.

Type:Article
Title:Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples.
Location:England
Language:English
Additional information:PMCID: PMC1757371
Keywords:Adolescent, Adrenal Cortex Hormones, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting, Patient Admission, Psychometrics, Quality of Life, Reproducibility of Results, Sickness Impact Profile
UCL classification:UCL > School of Life and Medical Sciences > Faculty of Brain Sciences

Archive Staff Only: edit this record